NEU neuren pharmaceuticals limited

My takeaways:seems to be a solid result for daybue with exciting...

  1. 445 Posts.
    lightbulb Created with Sketch. 196
    My takeaways:
    1. seems to be a solid result for daybue with exciting potential for europe getting closer.
    2. daybue seems to be more business as usual now and acadia just executing to plan to deliver a reliable recurring revenue stream for neu.
    3. interesting to see fragilex/retts mentioned on roadmap, look forward to the r&d day in june for a further update.
    4. With effects of additional workforce coming online 2nd half of year, I'm wondering if there is more than a sneaky chance of acadia exceeding daybue sales targets in the 2nd half of year.

    I was disappointed that none of the analysts queried the canadian price negotiations.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.54
Change
0.100(0.80%)
Mkt cap ! $1.559B
Open High Low Value Volume
$12.44 $12.73 $12.13 $11.07M 885.6K

Buyers (Bids)

No. Vol. Price($)
1 1215 $12.52
 

Sellers (Offers)

Price($) Vol. No.
$12.54 804 1
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.